ASP Isotopes receives conditional South African approval for Renergen acquisition

ASP Isotopes Inc.

Competition Commission approved as of July 23, 2025, subject to conditions acceptable to the Company.
Scheme effective in Q3 2025; final conditions must be fulfilled or waived by Sept 30, 2025.
Renergen is a South African producer of liquefied helium and LNG; combination targets $300M+ EBITDA by 2030.
Transaction expected to be highly accretive to ASPI's revenue, EBITDA, EPS, and cash flow from 2026.
Goal: create global leader in critical materials including isotopes, helium, and electronic gases.

item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.